Back
Protagonist Therapeutics Vs. Lifecore Biomedical Industry Stock Comparison
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
45.80
Seasonality Move:
18.58%
Sell
39
LFCR
Lifecore Biomedical
Last Price:
5.68
Seasonality Move:
2.29%
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.62. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Lifecore Biomedical (LFCR)
is a Sell
Is Lifecore Biomedical a Buy, Sell or Hold?
- The current Lifecore Biomedical [LFCR] share price is $5.93. The Score for LFCR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- LFCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.62
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
LFCR Stock Price Chart
What is Lifecore Biomedical's stock price today?
-
The Lifecore Biomedical share price today is $5.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LFCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | -140534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.33 - 47.23) | Buy |
| Bollinger Bands (100): | (35.43 - 45.45) | Buy |
LFCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 68.97 | Buy |
| Chaikin Money Flow: | 40145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.64 - 5.44) | Buy |
| Bollinger Bands (100): | (4.67 - 5.71) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.18 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 44.76 | Buy |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 47.35 | Buy |
| 20-day EMA: | 46.42 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 35.57 | Buy |
LFCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.5 | Buy |
| 20-day SMA: | 5.09 | Buy |
| 50-day SMA: | 5.02 | Buy |
| 200-day SMA: | 5.94 | Sell |
| 8-day EMA: | 5.52 | Buy |
| 20-day EMA: | 5.23 | Buy |
| 50-day EMA: | 5.15 | Buy |
| 200-day EMA: | 5.79 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Lifecore Biomedical Earnings Growth & LFCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $1.21 per share.
Protagonist Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lifecore Biomedical Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||